Total Payments
$13,572
2024 Payments
$2,050
Companies
55
Transactions
799
Medicare Patients
3,468
Medicare Billing
$607,243
Payment Breakdown by Category
Food & Beverage$13,125 (96.7%)
Education$447.45 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,125 | 778 | 96.7% |
| Education | $447.45 | 21 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,220 | 119 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,193 | 175 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $849.97 | 46 | $0 (2024) |
| Mylan Specialty L.P. | $663.87 | 34 | $0 (2023) |
| Insmed, Inc. | $645.57 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $635.85 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $620.17 | 38 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $601.04 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $587.82 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $487.88 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,050 | 104 | AstraZeneca Pharmaceuticals LP ($400.82) |
| 2023 | $1,963 | 106 | GlaxoSmithKline, LLC. ($316.41) |
| 2022 | $2,254 | 130 | AstraZeneca Pharmaceuticals LP ($336.09) |
| 2021 | $1,875 | 114 | AstraZeneca Pharmaceuticals LP ($470.19) |
| 2020 | $1,868 | 101 | GlaxoSmithKline, LLC. ($333.97) |
| 2019 | $1,440 | 93 | GlaxoSmithKline, LLC. ($254.07) |
| 2018 | $1,232 | 84 | GlaxoSmithKline, LLC. ($296.90) |
| 2017 | $890.33 | 67 | GlaxoSmithKline, LLC. ($196.26) |
All Payment Transactions
799 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $58.71 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Philips North America LLC | (AE4) Secretion Management (Device) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.20 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Respiratory | ||||||
| 11/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Philips North America LLC | (AE4) Secretion Management (Device) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Medical Device | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Insomnia | ||||||
| 10/04/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Medical Device | ||||||
| 10/04/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Medical Device | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 658 | 2,708 | $308,548 | $153,237 |
| 2022 | 12 | 813 | 2,996 | $310,635 | $157,354 |
| 2021 | 12 | 991 | 3,451 | $286,022 | $165,449 |
| 2020 | 13 | 1,006 | 3,926 | $268,292 | $131,204 |
Total Patients
3,468
Total Services
13,081
Medicare Billing
$607,243
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 1,088 | $206,693 | $102,045 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 508 | $68,217 | $34,961 | 51.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 124 | 231 | $9,232 | $4,511 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 24 | $6,425 | $3,340 | 52.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 25 | 26 | $6,230 | $3,024 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,944 | $2,741 | 46.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 56 | 211 | $4,507 | $2,276 | 50.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 20 | 27 | $392.00 | $182.26 | 46.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 93 | $396.00 | $112.24 | 28.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 45 | 476 | $512.00 | $45.01 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 920 | $176,640 | $89,318 | 50.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 138 | 321 | $43,656 | $21,687 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 127 | $34,544 | $17,703 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 157 | $21,352 | $11,204 | 52.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 141 | 332 | $13,280 | $6,703 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 71 | 310 | $6,510 | $3,411 | 52.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $6,030 | $3,098 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,048 | $2,166 | 53.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 15 | 15 | $2,805 | $1,511 | 53.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 20 | 34 | $544.00 | $288.90 | 53.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 36 | 159 | $636.00 | $210.17 | 33.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 55 | 587 | $590.00 | $53.44 | 9.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 707 | $115,948 | $69,088 | 59.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 173 | 594 | $67,375 | $42,396 | 62.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 89 | 200 | $44,200 | $25,772 | 58.3% |
About Dr. Leonard Cosmo, MD
Dr. Leonard Cosmo, MD is a Pulmonary Disease healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891763934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Cosmo, MD has received a total of $13,572 in payments from pharmaceutical and medical device companies, with $2,050 received in 2024. These payments were reported across 799 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($13,125).
As a Medicare-enrolled provider, Cosmo has provided services to 3,468 Medicare beneficiaries, totaling 13,081 services with total Medicare billing of $607,243. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Tampa, FL
- Active Since 03/14/2006
- Last Updated 01/22/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891763934
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,275
- GLASSIA (Biological) $724.84
- DUPIXENT (Biological) $703.50
- ACTHAR (Biological) $618.29
- Arikayce (Drug) $583.49
- SYMBICORT (Drug) $560.38
- Wakix (Drug) $553.97
- Yupelri (Drug) $487.93
- NUCALA (Biological) $486.68
- TEZSPIRE (Biological) $461.92
- BREZTRI (Drug) $367.45
- STIOLTO RESPIMAT (Drug) $311.63
- ANORO (Drug) $310.32
- WAKIX (Drug) $296.00
- OPSUMIT (Drug) $279.72
- FARXIGA (Drug) $261.18
- VRAYLAR (Drug) $237.68
- Xolair (Biological) $230.69
- Prolastin-C Liquid (Biological) $207.93
- QUVIVIQ (Drug) $200.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Tampa
Dr. Stephen Kreitzer, M.d, M.D
Pulmonary Disease — Payments: $38,725
Pulmonary Disease $38,725
Alexandre Furman, Md, MD
Pulmonary Disease — Payments: $13,506
Pulmonary Disease $13,506
Ryan Floyd, D.o, D.O
Pulmonary Disease — Payments: $11,994
Pulmonary Disease $11,994
David Weill, Md, MD
Pulmonary Disease — Payments: $11,802
Pulmonary Disease $11,802
Marwan Odeesh, M.d, M.D
Pulmonary Disease — Payments: $11,648
Pulmonary Disease $11,648
Dr. Adam Katz, M.d, M.D
Pulmonary Disease — Payments: $11,373
Pulmonary Disease $11,373